<code id='A7982B1031'></code><style id='A7982B1031'></style>
    • <acronym id='A7982B1031'></acronym>
      <center id='A7982B1031'><center id='A7982B1031'><tfoot id='A7982B1031'></tfoot></center><abbr id='A7982B1031'><dir id='A7982B1031'><tfoot id='A7982B1031'></tfoot><noframes id='A7982B1031'>

    • <optgroup id='A7982B1031'><strike id='A7982B1031'><sup id='A7982B1031'></sup></strike><code id='A7982B1031'></code></optgroup>
        1. <b id='A7982B1031'><label id='A7982B1031'><select id='A7982B1031'><dt id='A7982B1031'><span id='A7982B1031'></span></dt></select></label></b><u id='A7982B1031'></u>
          <i id='A7982B1031'><strike id='A7982B1031'><tt id='A7982B1031'><pre id='A7982B1031'></pre></tt></strike></i>

          leisure time

          leisure time

          author:fashion    Page View:7152
          Photo illustration of newspaper clips written by Lawrence K Altman about presidents' health – opinion coverage from STAT
          Alex Hogan/STAT

          When I interviewed Ronald Reagan about his health in 1980, he was 69 and poised to become the oldest person to be elected president. During our conversation, Reagan was mentally sharp. In a light moment he feigned a wrenched back and asked what I (a physician) would do for it.

          I asked him about his mother’s health, and he told me that his mother had symptoms suggestive of dementia before she died. I asked what he would do if, as president, he developed the same ailment, and how he would know he had it. His doctors would follow him, he said, and he would resign if they found evidence of cognitive decline. Years later, those remarks would seem particularly noteworthy.

          advertisement

          The interview was likely the first in which a future president and his doctors discussed the leader’s health prospectively. (That cooperation was short-lived; Reagan’s aides did not allow reporters to interview him or his doctors when he ran for re-election after what some regarded as a poor debate performance with Walter Mondale.)

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          FogPharma raises $145 million in rare Series E round
          FogPharma raises $145 million in rare Series E round

          FogPharmaCEOMathaiMammenBostonGlobePhotoImportOncologystartupFogPharmajustcloseda$145millionSeriesEr

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          ALS groups 'won't be played again' by the FDA, drug sponsors

          MattScozzariholdshisgirlfriendSabrinaParker'shandduringafriendshipceremonyinJacksonville,N.C.,inNove